BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1436 related articles for article (PubMed ID: 33742096)

  • 1. Functional profiling of COVID-19 respiratory tract microbiomes.
    Haiminen N; Utro F; Seabolt E; Parida L
    Sci Rep; 2021 Mar; 11(1):6433. PubMed ID: 33742096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults.
    Xu R; Lu R; Zhang T; Wu Q; Cai W; Han X; Wan Z; Jin X; Zhang Z; Zhang C
    Commun Biol; 2021 Feb; 4(1):240. PubMed ID: 33603076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
    Cyprian F; Sohail MU; Abdelhafez I; Salman S; Attique Z; Kamareddine L; Al-Asmakh M
    Int J Infect Dis; 2021 Apr; 105():540-550. PubMed ID: 33610778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
    Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
    Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome.
    Sulaiman I; Chung M; Angel L; Tsay JJ; Wu BG; Yeung ST; Krolikowski K; Li Y; Duerr R; Schluger R; Thannickal SA; Koide A; Rafeq S; Barnett C; Postelnicu R; Wang C; Banakis S; Pérez-Pérez L; Shen G; Jour G; Meyn P; Carpenito J; Liu X; Ji K; Collazo D; Labarbiera A; Amoroso N; Brosnahan S; Mukherjee V; Kaufman D; Bakker J; Lubinsky A; Pradhan D; Sterman DH; Weiden M; Heguy A; Evans L; Uyeki TM; Clemente JC; de Wit E; Schmidt AM; Shopsin B; Desvignes L; Wang C; Li H; Zhang B; Forst CV; Koide S; Stapleford KA; Khanna KM; Ghedin E; Segal LN
    Nat Microbiol; 2021 Oct; 6(10):1245-1258. PubMed ID: 34465900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
    Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
    Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 alters human microbiomes: a meta-analysis.
    Reuben RC; Beugnon R; Jurburg SD
    Front Cell Infect Microbiol; 2023; 13():1211348. PubMed ID: 37600938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota Status in COVID-19: An Unrecognized Player?
    Donati Zeppa S; Agostini D; Piccoli G; Stocchi V; Sestili P
    Front Cell Infect Microbiol; 2020; 10():576551. PubMed ID: 33324572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lower respiratory tract microbiome of critically ill patients with COVID-19.
    Gaibani P; Viciani E; Bartoletti M; Lewis RE; Tonetti T; Lombardo D; Castagnetti A; Bovo F; Horna CS; Ranieri M; Viale P; Re MC; Ambretti S
    Sci Rep; 2021 May; 11(1):10103. PubMed ID: 33980943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.
    Zuo T; Liu Q; Zhang F; Lui GC; Tso EY; Yeoh YK; Chen Z; Boon SS; Chan FK; Chan PK; Ng SC
    Gut; 2021 Feb; 70(2):276-284. PubMed ID: 32690600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Lung and Blood Microbiota Implicated in COVID-19 Prognosis.
    Dereschuk K; Apostol L; Ranjan I; Chakladar J; Li WT; Rajasekaran M; Chang EY; Ongkeko WM
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infection.
    Cribbs SK; Uppal K; Li S; Jones DP; Huang L; Tipton L; Fitch A; Greenblatt RM; Kingsley L; Guidot DM; Ghedin E; Morris A
    Microbiome; 2016 Jan; 4():3. PubMed ID: 26792212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection reduces human nasopharyngeal commensal microbiome with inclusion of pathobionts.
    Hoque MN; Sarkar MMH; Rahman MS; Akter S; Banu TA; Goswami B; Jahan I; Hossain MS; Shamsuzzaman AKM; Nafisa T; Molla MMA; Yeasmin M; Ghosh AK; Osman E; Alam SKS; Uzzaman MS; Habib MA; Mahmud ASM; Crandall KA; Islam T; Khan MS
    Sci Rep; 2021 Dec; 11(1):24042. PubMed ID: 34911967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
    Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
    Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the Human Oropharyngeal Microbiomes in SARS-CoV-2 Infection and Recovery Patients.
    Gao M; Wang H; Luo H; Sun Y; Wang L; Ding S; Ren H; Gang J; Rao B; Liu S; Wang X; Gao X; Li M; Zou Y; Liu C; Yuan C; Sun J; Cui G; Ren Z
    Adv Sci (Weinh); 2021 Oct; 8(20):e2102785. PubMed ID: 34423593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
    Ahlawat S; Asha ; Sharma KK
    Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Respiratory Microbiomes, Plasma Metabolites, and Immune Responses in Influenza A Virus and Methicillin-Resistant Staphylococcus aureus Coinfection.
    Chen Q; Liu M; Guo H; Wang K; Liu J; Wang Y; Lin Y; Li J; Li P; Yang L; Jia L; Yang J; Li P; Song H
    Microbiol Spectr; 2023 Aug; 11(4):e0524722. PubMed ID: 37318361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.